A recent article on Forbes.com discusses the significance of Aptar Pharma’s expanded relationship with Propeller Health to deliver Connected Medicines across multiple therapeutic areas. Announced May 30, this partnership, which includes a strategic equity investment by Aptar Pharma in Propeller Health, is “a move that signals the pharmaceutical industry’s growing interest in digital therapeutics.”
Read the full article to find out more.
Press Releases, Pharmaceutical
Forbes covers Aptar Pharma/Propeller Health work on connected medicine
Aptar Pharma Discusses with Forbes its Expanded Partnership with Propeller Health to Deliver Connected Medicines
31
May
2018

Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.